Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALOMA-2: Palbociclib + Letrozole in Advanced Breast Cancer
NCT01740427Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by Pfizer. Started Feb 2013; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01740427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740427.